These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12417830)

  • 1. Did you know? Improving preventive cardiology: The 33rd Bethesda Conference.
    Fletcher GF
    Prev Cardiol; 2002; 5(4):204-5. PubMed ID: 12417830
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventive Cardiology: How can we do Better? Proceedings of the 33rd Bethesda Conference. Bethesda, Maryland, USA. December 18, 2001.
    J Am Coll Cardiol; 2002 Aug; 40(4):580-651. PubMed ID: 12204487
    [No Abstract]   [Full Text] [Related]  

  • 3. Task force #5--the role of cardiovascular specialists as leaders in prevention: from training to champion. 33rd Bethesda Conference.
    Merz CN; Mensah GA; Fuster V; Greenland P; Thompson PD
    J Am Coll Cardiol; 2002 Aug; 40(4):641-51. PubMed ID: 12204493
    [No Abstract]   [Full Text] [Related]  

  • 4. Task force #3--getting results: who, where, and how? 33rd Bethesda Conference.
    Ades PA; Kottke TE; Miller NH; McGrath JC; Record NB; Record SS
    J Am Coll Cardiol; 2002 Aug; 40(4):615-30. PubMed ID: 12204491
    [No Abstract]   [Full Text] [Related]  

  • 5. Task force #1--magnitude of the prevention problem: opportunities and challenges. 33rd Bethesda Conference.
    Benjamin EJ; Smith SC; Cooper RS; Hill MN; Luepker RV
    J Am Coll Cardiol; 2002 Aug; 40(4):588-603. PubMed ID: 12204489
    [No Abstract]   [Full Text] [Related]  

  • 6. Global Atlas of Cardiovascular Disease 2000-2016: The Path to Prevention and Control.
    Thomas H; Diamond J; Vieco A; Chaudhuri S; Shinnar E; Cromer S; Perel P; Mensah GA; Narula J; Johnson CO; Roth GA; Moran AE
    Glob Heart; 2018 Sep; 13(3):143-163. PubMed ID: 30301680
    [No Abstract]   [Full Text] [Related]  

  • 7. [Polish forum for prevention guidelines on cardiovascular risk assessment].
    Podolec P; Kopeć G; Pajak A; Undas A; Kozek E; Tykarski A; Naruszewicz M; Stańczyk J; Opala G; Godycki-Cwirko M; Rynkiewicz A; Torbicki A; Musiał J
    Kardiol Pol; 2007 Jan; 65(1):100-4. PubMed ID: 17295170
    [No Abstract]   [Full Text] [Related]  

  • 8. Task force #2--the cost of prevention: can we afford it? Can we afford not to do it? 33rd Bethesda Conference.
    Krumholz HM; Weintraub WS; Bradford WD; Heidenreich PA; Mark DB; Paltiel AD
    J Am Coll Cardiol; 2002 Aug; 40(4):603-15. PubMed ID: 12204490
    [No Abstract]   [Full Text] [Related]  

  • 9. AHA Conference Proceedings. Prevention conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: executive summary. American Heart Association.
    Smith SC; Greenland P; Grundy SM
    Circulation; 2000 Jan 4-11; 101(1):111-6. PubMed ID: 10618313
    [No Abstract]   [Full Text] [Related]  

  • 10. Current European guidelines on cardiovascular disease prevention in clinical practice: an American perspective.
    Wang SS; Smith SC
    Pol Arch Med Wewn; 2008; 118(1-2):16-8. PubMed ID: 18405168
    [No Abstract]   [Full Text] [Related]  

  • 11. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts).
    De Backer G; Ambrosioni E; Borch-Johnsen K; Brotons C; Cifkova R; Dallongeville J; Ebrahim S; Faergeman O; Graham I; Mancia G; Cats VM; Orth-Gomér K; Perk J; Pyörälä K; Rodicio JL; Sans S; Sansoy V; Sechtem U; Silber S; Thomsen T; Wood D;
    Atherosclerosis; 2004 Apr; 173(2):381-91. PubMed ID: 15195638
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there a future for preventive cardiology?
    Luepker RV
    Am J Prev Med; 1990; 6(2 Suppl):98-100. PubMed ID: 2383419
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular guidelines for women released.
    AWHONN Lifelines; 2001 Dec-2002 Jan; 5(6):79-82. PubMed ID: 11778469
    [No Abstract]   [Full Text] [Related]  

  • 14. The 2000-2016 WHF Global Atlas of CVD: Take Two.
    Moran AE; Wood DA; Narula J
    Glob Heart; 2018 Sep; 13(3):139-141. PubMed ID: 30360786
    [No Abstract]   [Full Text] [Related]  

  • 15. The Road to 25×25: Update on WHF CVD Roadmaps.
    Grainger-Gasser A; Perel P; Lagier-Hässig L; Wood D
    Glob Heart; 2017 Sep; 12(3):269-270. PubMed ID: 27720665
    [No Abstract]   [Full Text] [Related]  

  • 16. British and American prevention guidelines: different committees, same science, considerable agreement.
    Greenland P
    Heart; 2014 May; 100(9):678-9. PubMed ID: 24667310
    [No Abstract]   [Full Text] [Related]  

  • 17. Routine vitamin supplementation to prevent cancer and cardiovascular disease: recommendations and rationale.
    U.S. Preventive Services Task Force
    Am Fam Physician; 2003 Dec; 68(12):2422-4. PubMed ID: 14705762
    [No Abstract]   [Full Text] [Related]  

  • 18. Task force #4--adherence issues and behavior changes: achieving a long-term solution. 33rd Bethesda Conference.
    Ockene IS; Hayman LL; Pasternak RC; Schron E; Dunbar-Jacob J
    J Am Coll Cardiol; 2002 Aug; 40(4):630-40. PubMed ID: 12204492
    [No Abstract]   [Full Text] [Related]  

  • 19. CVD prevention in women: a practice update.
    Campos-Outcalt D
    J Fam Pract; 2011 Jul; 60(7):421-5. PubMed ID: 21731920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines on cardiovascular disease prevention in clinical practice: the European perspective.
    Graham IM
    Curr Opin Cardiol; 2005 Sep; 20(5):430-9. PubMed ID: 16093763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.